BioNTech SE BNTX
NASDAQ BNTX
$91.88 +0.71 (+0.77%)
As of: Oct 21, 2026 · 2:41 PM EDT

BioNTech SE (BNTX) Current Deferred Tax Assets (2020 - 2025)

Updated

BioNTech SE's Current Deferred Tax Assets came in at $73.6 million for Q3 2022, down 8.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Current Deferred Tax Assets (2020 - 2025) Analysis & Trends

At the end of FY2021, BioNTech SE's Current Deferred Tax Assets was $55.48 million, up 73.5% from FY2020.

  • Going back by year, Current Deferred Tax Assets was $31.97 million in FY2020.
  • The five-year range for quarterly Current Deferred Tax Assets is $33.38 million (Q4 2020) to $90.57 million (Q1 2022).
  • Business Quant data shows BNTX's Current Deferred Tax Assets at $80.67 million (Q2 2022), $90.57 million (Q1 2022) and $55.48 million (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn
10 BioNTech SE 22.19 Bn -24.28 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 80.23 Mn
Dec 31, 2024 -17.07 Mn
Dec 31, 2023 -15.83 Mn
Sep 30, 2022 71.76 Mn
Jun 30, 2022 78.98 Mn
Mar 31, 2022 90.08 Mn
Dec 31, 2021 54.93 Mn
Dec 31, 2020 34.44 Mn
API Access

BioNTech SE Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=BNTX&period=max&api_key=YOUR_API_KEY